Complement factor B expression profile in a spontaneous uveitis model

Immunobiology

Volumn 215, Issue 12, 2010, Pages 949-955

  Zipplies, Johanna K ^a   Kirschfink, Michael ^b   Amann, Barbara ^a   Hauck, Stefanie M ^c   Stangassinger, Manfred ^a   Deeg, Cornelia A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Autoimmune; Complement system; Serum; Uveitis; Vitreous

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIGEN; BB NEOANTIGEN; CD68 ANTIGEN; COMPLEMENT COMPONENT C3D; COMPLEMENT FACTOR I; COMPLEMENT MEMBRANE ATTACK COMPLEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE MODEL; HORSE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECURRENT DISEASE; SIGNAL TRANSDUCTION; UVEITIS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AUTOIMMUNE DISEASES; COMPLEMENT ACTIVATION; COMPLEMENT C3B; COMPLEMENT C3D; COMPLEMENT FACTOR B; COMPLEMENT MEMBRANE ATTACK COMPLEX; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HORSE DISEASES; HORSES; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; RETINA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UVEITIS;

EID: 78049238579     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.02.003     Document Type: Article

References (47)

1. Bora N.S., Jha P., Bora P.S. The role of complement in ocular pathology. Semin. Immunopathol 2008.
2. Caicedo A., Espinosa-Heidmann D.G., Pina Y., Hernandez E.P., Cousins S.W. Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp. Eye Res. 2005, 81:38-47.
3. Carroll M.C. The complement system in B cell regulation. Mol. Immunol. 2004, 41:141-146.
4. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5:981-986.
5. Caspi R.R. Ocular autoimmunity: the price of privilege?. Immunol. Rev. 2006, 213:23-35.
6. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008, 31:252-256.
7. Deeg C.A. Ocular immunology in equine recurrent uveitis. Vet. Ophthalmol. 2008, 11(Suppl 1):61-65.
8. Deeg C.A., Altmann F., Hauck S.M., Schoeffmann S., Amann B., Stangassinger M., Ueffing M. Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics 2007, 7:1540-1548.
9. Deeg C.A., Amann B., Raith A.J., Kaspers B. Inter- and intramolecular epitope spreading in equine recurrent uveitis. Invest. Ophthalmol. Vis. Sci. 2006, 47:652-656.
10. Deeg C.A., Ehrenhofer M., Thurau S.R., Reese S., Wildner G., Kaspers B. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp. Eye Res. 2002, 75:127-133.
11. Deeg C.A., Hauck S.M., Amann B., Pompetzki D., Altmann F., Raith A., Schmalzl T., Stangassinger M., Ueffing M. Equine recurrent uveitis-a spontaneous horse model of uveitis. Ophthalmic Res. 2008, 40:151-153.
12. Deeg C.A., Kaspers B., Gerhards H., Thurau S.R., Wollanke B., Wildner G. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest. Ophthalmol. Vis. Sci. 2001, 42:393-398.
13. Deeg C.A., Pompetzki D., Raith A.J., Hauck S.M., Amann B., Suppmann S., Goebel T.W., Olazabal U., Gerhards H., Reese S., Stangassinger M., Kaspers B., Ueffing M. Identification and functional validation of novel autoantigens in equine uveitis. Mol. Cell. Proteomics 2006, 5:1462-1470.
14. Deeg C.A., Reese S., Gerhards H., Wildner G., Kaspers B. The uveitogenic potential of retinal S-antigen in horses. Invest Ophthalmol. Vis. Sci. 2004, 45:2286-2292.
15. Deeg C.A., Thurau S.R., Gerhards H., Ehrenhofer M., Wildner G., Kaspers B. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur. J. Immunol. 2002, 32:2598-2606.
16. Frank M.M., Fries L.F. The role of complement in inflammation and phagocytosis. Immunol. Today 1991, 12:322-326.
17. Fujiwara N., Kobayashi K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy 2005, 4:281-286.
18. Gilger B.C., Malok E., Cutter K.V., Stewart T., Horohov D.W., Allen J.B. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet. Immunol. Immunopathol. 1999, 71:17-28.
19. Hauck S.M., Schoeffmann S., Amann B., Stangassinger M., Gerhards H., Ueffing M., Deeg C.A. Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis. J. Proteome Res. 2007, 6:2121-2131.
20. Holers V.M. The spectrum of complement alternative pathway-mediated diseases. Immunol. Rev. 2008, 223:300-316.
21. Huang Y., Krein P.M., Muruve D.A., Winston B.W. Complement factor B gene regulation: synergistic effects of TNF-alpha and IFN-gamma in macrophages. J. Immunol. 2002, 169:2627-2635.
22. Huang Y., Krein P.M., Winston B.W. Characterization of IFN-gamma regulation of the complement factor B gene in macrophages. Eur.l J. Immunol. 2001, 31:3676-3686.
23. Ingram G., Hakobyan S., Robertson N.P., Morgan B.P. Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clin. Exp. Immunol. 2009, 155:128-139.
24. Jha P., Bora P.S., Bora N.S. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol. Immunol. 2007, 44:3901-3908.
25. Jha P., Sohn J.H., Xu Q., Nishihori H., Wang Y., Nishihori S., Manickam B., Kaplan H.J., Bora P.S., Bora N.S. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2006, 47:1030-1038.
26. Jha P., Sohn J.H., Xu Q., Wang Y., Kaplan H.J., Bora P.S., Bora N.S. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J. Immunol. 2006, 176:7221-7231.
27. Kelchtermans H., Billiau A., Matthys P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 2008, 29:479-486.
28. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
29. Kinoshita T. Biology of complement: the overture. Immunol. Today 1991, 12:291-295.
30. Laszlo D.J., Henson P.M., Remigio L.K., Weinstein L., Sable C., Noble P.W., Riches D.W. Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states. Am. J. Pathol. 1993, 143:587-597.
31. Laufer J., Katz Y., Passwell J.H. Extrahepatic synthesis of complement proteins in inflammation. Mol. Immunol. 2001, 38:221-229.
32. Longhi M.P., Harris C.L., Morgan B.P., Gallimore A. Holding T cells in check-a new role for complement regulators?. Trends Immunol. 2006, 27:102-108.
33. Mitchell T.J., Naughton M., Norsworthy P., Davies K.A., Walport M.J., Morley B.J. IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. J. Immunol. 1996, 156:4429-4434.
34. Morgan B.P., Gasque P. Extrahepatic complement biosynthesis: where, when and why?. Clin. Exp. Immunol. 1997, 107:1-7.
35. Nussenblatt R.B. The natural history of uveitis. Int. Ophthalmol. 1990, 14:303-308.
36. Pangburn M.K., Muller-Eberhard H.J. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J. Exp. Med. 1980, 152:1102-1114.
37. Reynolds R., Hartnett M.E., Atkinson J.P., Giclas P.C., Rosner B., Seddon J.M. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest. Ophthalmol. Vis. Sci. 2009, 50:5818-5827.
38. Scholl H.P., Charbel Issa P., Walier M., Janzer S., Pollok-Kopp B., Borncke F., Fritsche L.G., Chong N.V., Fimmers R., Wienker T., Holz F.G., Weber B.H., Oppermann M. Systemic complement activation in age-related macular degeneration. PLoS One 2008, 3:e2593.
39. Sjoberg A.P., Trouw L.A., Blom A.M. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009, 30:83-90.
40. Toapanta F.R., Ross T.M. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunol. Res. 2006, 36:197-210.
41. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
42. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J. Exp. Med. 1980, 151:501-516.
43. Winston B.W., Krein P.M., Mowat C., Huang Y. Cytokine-induced macrophage differentiation: a tale of 2 genes. Clin. Invest. Med. 1999, 22:236-255.
44. Zamiri P., Masli S., Streilein J.W., Taylor A.W. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci. 2006, 47:3912-3918.
45. Zipfel P.F. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett 2009.
46. Zipplies J.K., Hauck S.M., Schoeffmann S., Amann B., Stangassinger M., Ueffing M., Deeg C.A. Serum PEDF levels are decreased in a spontaneous animal model for human autoimmune uveitis. J. Proteome Res. 2009, 8:992-998.
47. Zipplies J.K., Hauck S.M., Schoffmann S., Amann B., van der Meijden C.H., Stangassinger M., Ueffing M., Deeg C. Kininogen is decreased in peripheral blood stream but increased in target tissue of autoimmune uveitis. Invest. Ophthalmol. Vis. Sci 2009.